BioCryst Pharmaceuticals Aktie Analyse
22.06.18 | BioCryst Pharmaceuticals Neutral | Seaport Global Securities | |
20.12.17 | BioCryst Pharmaceuticals Equal weight | Barclays Capital | |
15.09.17 | BioCryst Pharmaceuticals Sector Perform | RBC Capital Markets | |
12.11.07 | BioCryst Pharmaceuticals average | Caris & Company, Inc. | |
20.09.07 | BioCryst Pharmaceuticals average | Caris & Company, Inc. | |
29.08.07 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
20.06.07 | BioCryst Pharmaceuticals average | Caris & Company | |
29.03.07 | BioCryst Pharmaceuticals market perform | CE Unterberg, Towbin | |
Werbung
|
|||
19.02.07 | BioCryst Pharmaceuticals neutral | Jaindl & Mautz | |
11.12.06 | BioCryst Pharmaceuticals Average | Caris & Company | |
14.11.06 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
11.10.06 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
28.04.06 | BioCryst Pharmaceuticals Market Perform | CE Unterberg, Towbin | |
20.04.06 | BioCryst Pharmaceuticals | Caris & Company | |
27.10.05 | BioCryst Pharmaceuticals Market Perform | Rodman & Renshaw |